ArticleOncoTargets and therapy2017

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study.

Yi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.